Playlist


Government Summer Recess: Cabinet of Ministers of Turkmenistan Begins Annual Leave on August 1
03 Aug. 13:42Members of the Cabinet of Ministers of Turkmenistan officially commenced their annual leave on August 1, during which they will have the opportunity to recreate and access health services at national sanatoriums and the Avaza National Tourist Zone. The announcement was made by President Serdar Berdimuhamedov during a Cabinet meeting, as reported by the State News Agency of Turkmenistan (TDH).
In line with established practice, this leave schedule does not extend to executives of the agricultural sector or the governors (hakims) of the provinces. Regional officials will take their annual leave later in the year, following the completion of the autumn cotton harvest.
Reviewing the nation's performance over the first seven months of the year, President Serdar Berdimuhamedov noted steady macroeconomic progress across key sectors. The Head of State highlighted that structural reforms and facility modernizations have effectively maintained Turkmenistan's Gross Domestic Product (GDP) growth rate at 6.3 percent for the reporting period.
The meeting concluded with the review and approval of several state matters, after which President Serdar Berdimuhamedov extended wishes of health, well-being, and continued success to the members of the government.
Also read


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.